Patrik Andersson, PhDRNA Therapeutics Safety Lead at AstraZenecaSpeaker
Agenda Sessions
Evolution of Therapeutic Oligo Safety
On Demand - Premium OnlyView Session
Evolution of Therapeutic Oligo Safety